SK Life Science, Inc. has unveiled Epilepsy Connect, a new digital platform aimed at supporting advanced practice providers (APPs) in epilepsy care. The platform offers complimentary access to educational resources, accredited webinars, and peer networking tools for APPs within the United States. Epilepsy Connect includes on-demand courses covering various aspects of epilepsy care and allows for peer-to-peer networking among APPs nationwide.
The launch of Epilepsy Connect is part of SK Life Science, Inc.’s efforts to empower and support APPs as crucial members of the epilepsy care team, particularly with 3.4 million individuals in the United States living with epilepsy. Insights from the Hope, Hesitancy, and Hard Truths survey reveal a gap in treatment discussions, highlighting the need for accessible educational resources for APPs. The upcoming American Academy of Neurology Annual Meeting will provide further details on the survey methodology.
The platform is designed to enhance APPs’ knowledge and skills in epilepsy care, strengthen patient conversations, and ultimately improve care for those living with epilepsy. APPs can enroll for free and access a range of educational resources, including epilepsy courses, accredited webinars, and the APP Connect feature for networking with peers across the country.
Epilepsy Connect is a centralized education platform focusing on the needs of U.S. APPs to provide ongoing learning opportunities, professional development, and peer networking in epilepsy care. The platform aims to support APPs in delivering comprehensive and patient-centered epilepsy care. Interested APPs can learn more and register on the Epilepsy Connect website.
SK Life Science, Inc., based in Paramus, New Jersey, is dedicated to advancing epilepsy awareness, education, and support for APPs. The company, along with SK Biopharmaceuticals Co., Ltd., is at the forefront of developing new treatments for central nervous system disorders and oncology, utilizing innovative research and development techniques. Visit www.sklifescienceinc.com for more information.
SOURCE: SK Life Science, Inc.
